MediBuddy is the award-winning technology platform from Medi Assist that transforms the health insurance industry at the very core. MediBuddy, with its diverse offerings for various stakeholders of the health benefits industry, makes the process of discovering, accessing, utilizing and monitoring health benefits seamless, real-time and virtually paperless. Here is how MediBuddy addresses the varying needs of the diverse stakeholders in the health benefits ecosystem: • Members: MediBuddy is a comprehensive one-stop health benefits management platform that gives members access to inpatient, outpatient, wellness, fitness and preventive care services offered by our curated network of healthcare providers. Accessible both as an online portal as well as a mobile app, MediBuddy gives members unparalleled, real-time access to all their health benefits anytime and from anywhere. • Corporate HR: Individual logins for HR members provide them a transparent view of everyday claims management. The dashboard gives real-time information about claims in process, settled, denied, etc., and also allows HR members to raise, track or manage claims on behalf of their employees. • Insurers and decision makers: MediBuddy offers near-real-time MIS report of all critical parameters that allows for comparative study across years and policies with ease. Our business analytics module packs the power of multiple pivot tables into simple drop-downs for deep, decisive insights into your portfolio. Simple, graphical representation of data enables easy comparison, trend mapping and predictive analysis. • Hospitals: Medi Assist network hospitals enjoy real-time access to all cashless claims with MediBuddy. From receiving alerts for planned eCashless hospitalization, to raising preauthorization, enhancement and final billing, and also dashboards to view total claims settled, in-process, etc., hospitals get all the information they need on one common interface.
Private Equity Round in 2022
Concung.com, founded in 2011 and based in Vietnam, operates as a retail chain specializing in maternal and baby products. The company, officially known as Con Can Joint Stock Company, focuses on developing a comprehensive retail system for mothers and children, which includes Baby, Toycity, and Con Cung Fashion stores. With a commitment to providing high-quality, safe products at reasonable prices, Concung ensures that all items have clear origins and meet customer demands. The company has experienced significant growth, with over 230 outlets across 40 provinces, and aims to expand to all 64 provinces in Vietnam. Concung's business model incorporates modern technology to streamline operations and reduce costs, enhancing affordability for consumers. The workforce comprises around 1,500 trained professionals dedicated to delivering excellent service. Furthermore, Concung collaborates with various international manufacturers to offer the best products tailored for Vietnamese children.
Private Equity Round in 2021
Encube Ethicals Pvt. Ltd. is a contract development and manufacturing organization based in Mumbai, India, with an additional plant in Goa. Founded in 1995, the company focuses on developing and manufacturing topical semisolid formulations, including ointments, gels, creams, solutions, and lotions, which address various topical disorders and diseases. In addition to formulation development, Encube Ethicals offers analytical development, packaging development, lab scale stability studies, pilot scale and exhibit batches, technology transfer, and commercialization services. The company serves a diverse clientele, including pharmaceutical and cosmetic organizations across the United States, Europe, India, and other international markets.
AIG Hospitals is a Gastroenterology hospital that believes and preaches that excellence is a way of life. It offers transplant surgeries including Liver, Kidney, Heart, Pancreas, and Islet Cell. It believes in creating a positive and nurturing environment that is conducive to healing. It was founded in 1986 and is headquartered in Hyderabad, India.
Private Equity Round in 2019
Akums Drugs & Pharmaceuticals Ltd, Haridwar, (India), is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing and has rapidly emerged as the premier integrated pharmaceutical company in India. Akums' existing six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml), Lyophilized Injections and Eye / Ear / Nasal Drops in FORM FILL & SEAL and THREE PIECE Packs. Akums' first Plant, commissioned in the year 2004 is the State-of-the-Art manufacturing facility producing tablets, capsules, soft - Gelatin capsules & Dry Syrups with huge per day manufacturing capacity in all sections and has separate blocks for Beta Lactums, Non-Beta Lactums, Cephalosporin & Penicillin preparations.
Private Equity Round in 2019
Akums Drugs & Pharmaceuticals Ltd, Haridwar, (India), is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing and has rapidly emerged as the premier integrated pharmaceutical company in India. Akums' existing six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml), Lyophilized Injections and Eye / Ear / Nasal Drops in FORM FILL & SEAL and THREE PIECE Packs. Akums' first Plant, commissioned in the year 2004 is the State-of-the-Art manufacturing facility producing tablets, capsules, soft - Gelatin capsules & Dry Syrups with huge per day manufacturing capacity in all sections and has separate blocks for Beta Lactums, Non-Beta Lactums, Cephalosporin & Penicillin preparations.
Private Equity Round in 2018
Strand Life Sciences Pvt Ltd. is a clinical diagnostics and genomic profiling company based in Bengaluru, India, that develops and markets diagnostic tests for cancer and inherited diseases. The company provides a wide range of diagnostic solutions across oncology, genetics, fertility, women’s health, infectious diseases, and general wellness. In addition to its diagnostic offerings, Strand Life Sciences specializes in bioinformatics services, including variant curation, interpretation, and reporting platforms. Its advanced software, such as GeneSpring and Strand NGS, enables comprehensive analysis of genomic data, supporting research and clinical applications. Strand's innovative StrandOmics platform enhances the value of its cloud database with each DNA test conducted, driving demand for more sophisticated analytics. Established in 2000, the company has achieved profitability since 2007 and has expanded its services to over 100 hospitals in India, while also initiating entry into the U.S. market.
Private Equity Round in 2018
Lablink (M) Sdn Bhd is a medical laboratory operator based in Kuala Lumpur, Malaysia, founded in 1989. The company specializes in a comprehensive range of laboratory services, including hematology, chemical pathology, immunology, serology, histology, medical microbiology, cytology, molecular diagnostics, and health screening. Lablink offers specimen collection services from private clinics and hospitals, as well as mobile laboratory services for walk-in customers. By employing advanced technological systems and safe procedures, Lablink aims to provide accurate diagnoses, facilitating effective patient care. The company operates as a subsidiary of Kumpulan Perubatan (Johor) Sdn. Bhd.
AIG Hospitals is a Gastroenterology hospital that believes and preaches that excellence is a way of life. It offers transplant surgeries including Liver, Kidney, Heart, Pancreas, and Islet Cell. It believes in creating a positive and nurturing environment that is conducive to healing. It was founded in 1986 and is headquartered in Hyderabad, India.
Private Equity Round in 2015
Soho Global Health is a healthcare company based in Jakarta Timur, Indonesia, founded in 1946. It specializes in researching, developing, and marketing specialty medicines targeting therapeutic areas such as immunomodulation, respiratory issues, inflammation, and liver diseases. The company also offers a range of nonprescription products aimed at disease treatment and prevention. In addition to pharmaceuticals, Soho Global Health provides contract manufacturing services for various dosage forms and engages in distribution and logistics. Its product portfolio includes wellness items focused on body defense, stamina, brain health, skin care, and weight management. The company markets medical devices and equipment for wound care, general hospital use, surgery, orthopedics, and in-vitro diagnostics. Furthermore, it offers services in product registration, marketing intelligence, and sales support.
Private Equity Round in 2013
Capricorn Food Products India Limited is a prominent food processing company based in Chennai, India, specializing in the production and export of a variety of processed fruit and vegetable products. Founded in 1998, the company offers a diverse range of items including mango pulp, tomato paste, and individually quick frozen (IQF) fruits and vegetables. These products serve as key ingredients for various applications such as juices, packaged foods, dairy products, and infant nutrition. Capricorn is recognized for its commitment to quality and innovation in the fruit and vegetable processing industry, catering to both domestic and international markets across Europe, the Middle East, Asia Pacific, Africa, and North America. The company has established itself as a leader in manufacturing tropical fruit purees and concentrates, as well as a variety of frozen vegetables.
Iconoculture, Inc. is a provider of consumer research and advisory services, specializing in market trends and consumer segmentation. Founded in 1992 and based in Minneapolis, the company offers a range of products and services aimed at helping businesses understand consumer behavior and cultural trends. Its U.S. Advisory Service grants access to a comprehensive cultural research database, complemented by monthly e-bulletins and an annual trend report. Iconoculture also supports global-facing brands through its Global View service and offers a customizable web interface via Custom View. Additionally, the company operates IconoCommunities, which are consumer-centric social networks designed to capture consumer moods and motivations. The annual Iconosphere conference provides insights into emerging trends, while Consumer Outlooks delivers targeted demographic and market information. Custom research and consulting services are also available to meet specific client needs. Iconoculture became a subsidiary of Corporate Executive Board Co. in 2010.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.